2013 ACR/ARHP Annual Meeting Archives - Page 2 of 193

Abstract Number: 245

C-Reactive Protein But Not Erythrocyte Sedimentation Rate Is Associated With Decrease In Muscle Strength In Patients With Knee Osteoarthritis: A 2 Year Follow Up Study
Abstract Number: 731

C3 Activation Is Associated With The Disease Activity Of Microscopic Polyangiitis
Abstract Number: 2567

Cadherin-11 Regulates Pulmonary Fibrosis In Bleomycin-Induced Lung Injury
Abstract Number: 2724

cAMP Responsive Element Modulator (CREM)α Governs CD8 Expression and Contributes to the Generation of CD3⁺CD4^–CD8^– T Cells in Lupus
Abstract Number: 2549

Can Biomarkers Provide An Objective Standard Against Which To Assess Lupus Clinical Endpoint Measures?
Abstract Number: 2581

Can Changes In NT-Probnp Predict Early Response To Therapy and Prognosis In Systemic Sclerosis Associated Pre-Capillary Pulmonary Hypertension?
Abstract Number: 188

Can MDHAQ/RAPID3 Be Used In Usual Care Of Patients With Systemic Lupus Erythematosus?
Abstract Number: 402

Can Modulators Of Inflammation Serve As Biomarkers For Subclinical Atherosclerosis In Rheumatoid Arthritis?
Abstract Number: 232

Can Musculoskeletal Ultrasonography Examination (MSUS) Predict Outcome In Shoulder Impingement Syndrome (SIS)? A Prospective Blinded Study
Abstract Number: 1708

Can People With Rheumatoid Arthritis Self Monitor Their Disease Activity?
Abstract Number: 2759

Can RA Registries Provide Contextual Safety Data For Modern RCTs?
Abstract Number: 192

Can Routine Assessment Of Patient Index Data (RAPID)3 Be Used As a Patient Reported Assessment Tool For Patients With Ankylosing Spondylitis?
Abstract Number: 1946

Can Satisfactory Reliability Of The 7-Joint Ultrasound Score Be Attained By Inexperienced Readers In a Single Calibration Exercise? Results From The Biodam Program
Abstract Number: 2803

Can Ultrasonographic Findings Predict Response To Tumor Necrosis Factor-α Inhibitor Treatment In Rheumatoid Arthritis?
Abstract Number: 1208

Canakinumab In Patients With FMF
Abstract Number: 270

Canakinumab In The Treatment Of Systemic Juvenile Idiopathic Arthritis: Results From a 12-Week Pooled Post-Hoc Analysis For Efficacy
Abstract Number: 1783

Canakinumab Treatment In Active Hyper-IgD With Periodic Fever Syndrome
Abstract Number: 2747

Canakinumab Treatment In Schnitzler’s Syndrome: A Multi-Center Randomized Placebo-Controlled 4-Month Study
Abstract Number: 1206

Canakinumab Treatment Regimens In CAPS Patients
Abstract Number: 590

Candidate Urinary Biomarkers May Predict The Future Development Of Renal Functional Loss With Lupus Nephritis In Children and Adults
Abstract Number: 853

Capillaroscopy Compared With Color Doppler Ultrasound Of Digital Arteries For Distinguishing Primary From Secondary Raynaud’s Phenomenon
Abstract Number: 1829

Carboxypeptidase B2 Down-Regulates Osteoclast Activation In Inflammation
Abstract Number: 739

Cardiac Involvement In Granulomatosis With Polyangiitis
Abstract Number: 406

Cardiovascular Case Fatality In Rheumatoid Arthritis Is Decreasing; Results From a Current Low Disease Activity Rheumatoid Arthritis Cohort and Review Of The Literature
Abstract Number: 266

Cardiovascular Disease In Osteoarthritis: Hip Versus Knee and The Influence Of Multiple Symptomatic Joint Involvement
Abstract Number: 2448

Cardiovascular Disease Is Associated With Worse Functional Outcomes In Ankylosing Spondylitis
Abstract Number: 833

Cardiovascular Diseases In Rheumatoid Arthritis: Can Early Treatment With Disease-Modifying Antirheumatic Drugs Alter The Risk?
Abstract Number: 225

Cardiovascular Involvement In Erdheim-Chester Disease: A Magnetic Resonance Imaging Study On Seven Patients
Abstract Number: 752

Cardiovascular Outcomes Are Worse In Microscopic Polyangiitis Compared To Granulomatosis With Polyangiitis: Data From An Inception Cohort Of Patients With Anti-Neutrophil Cytoplasm Antibody Associated Systemic Vasculitis
Abstract Number: 1671

Cardiovascular Risk At Incidence Of Giant Cell Arteritis: A Population Based Retrospective Cohort Study
Abstract Number: 286

Cardiovascular Risk In Adults With Juvenile Idiopathic Arthritis
Abstract Number: 372

Cardiovascular Risk In Intensively Treated Rheumatoid Arthritis: Comparison To An Osteoarthritis Population. First Prospective Analysis Of The ACT-CVD Cohort
Abstract Number: 1975

Cardiovascular Risk Stratification In Rheumatic Diseases : Carotid Ultrasound Is More Sensitive Than Coronary Artery Calcification Score To Detect Subclinical atherosclerosis In Patients With Rheumatoid Arthritis
Abstract Number: 440

Cardiovascular Safety Findings In Rheumatoid Arthritis Patients Treated With Tofacitinib, A Novel, Oral Janus Kinase Inhibitor
Abstract Number: 384

Carotid Artery Plaques Are Associated With Coronary Atherosclerosis In Patients With Inflammatory Joint Diseases Independent Of Several Cardiovascular Risk Calculators
Abstract Number: 2763

Carotid Atherosclerosis As a Predictor Of Mortality In Rheumatoid Arthritis
Abstract Number: 50

Cartilage Matrix Remodeling and Activation Of Canonical Wnt- Signaling Precedes Calcification and OA-Like Changes In Mice
Abstract Number: 156

Cartilage Peptide Profiling: Identifying Novel OA Biomarkers For Early Disease Detection
Abstract Number: 85

Cartilaginous Uric Acid Deposition In Advanced Osteoarthritis: Innocent Bystander Or Promotor Of Cartilage Destruction?
Abstract Number: 2744

Caspase 8 Modulates The Polarisome To Prevent Lung Fibrosis In a Murine Ssc-Like Disease Model
Abstract Number: 11

Catastrophic Antiphospholipid Syndrome (CAPS): Clinical, Immunologic Features, and Outcome Of 441 Patients From The “CAPS Registry”
Abstract Number: 1320

Categorization Of Rheumatoid Arthritis Subjects By Rheumatoid Factor and Anti-Cyclic Citrullinated Autoantibody Status Identifies Rheumatoid Arthritis Subjects With Different Characteristics
Abstract Number: 614

Causes Of Mortality In Lupus Patients Followed Prospectively At a Large Single-Centre Lupus Clinic
Abstract Number: 820

CC-220: A Clinical Stage Immunomodulatory, Antifibrotic Drug For Systemic Sclerosis
Abstract Number: 1642

CD25+CD39+ Regulatory T Cells Are Enriched At The Site Of Inflammation Of Patients With Rheumatoid Arthritis and Impaired In Suppressing IL-17A Secretion
Abstract Number: 2419

CDK6 Transcripts Expression Control By The Synoviocyte Proliferation Gene, SPACIA1
Abstract Number: L21

Celastrol, a Triterpene from Tripterygium Wilfordii, Inhibits Neutrophil Extracellular Trap Formation
Abstract Number: 1729

Cell Cycle Regulation Therapy Combined With Cytokine Blockade Enhances Anti-Arthritic Effects Without Increase Of Immune Suppression
Abstract Number: 730

Cell-Mediated Immune Responses To Influenza and Herpesvirus Antigen Stimulation Are Conserved But Adversely Impacted By Immunosuppressive Therapy and Active Infection In Patients With Granulomatosis With Polyangiitis
Abstract Number: 1847

Certolizumab-Pegol Induces Reverse Signaling Through Membrane TNF Via Calcineurin Activation In Human Monocytes. Relevance In Inflammation
Abstract Number: L12

Cetrorelix, a Gonadotropin-Releasing Hormone Antagonist, Demonstrates Efficacy and Significantly Reduces Proinflammatory Cytokines in Patients with Active Longstanding Rheumatoid Arthritis with High Gonadotropin Levels: A Proof-of-Concept, Double-Blind, Randomized Trial
Abstract Number: 1130

Change In Knee Osteophyte Volume By Semi-Automated Method In Knee Osteoarthritis Over Four Years Using 3T DESS 3D MRI
Abstract Number: 2387

Change of serum Amyloid a predict The Effect Of Biological Treatment In Rheumatoid Arthritis Patient
Abstract Number: 2458

Change Over Time In The Profile Of Ankylosing Spondylitis Patients Treated With Infliximab In Canadian Routine Care
Abstract Number: 416

Changes In Body Composition On Two Different Glucocorticoid Regimens In Early RA: Experience From The Cobra-Light Trial
Abstract Number: 950

Changes In Circulating Visfatin Levels By Different Anti-Rheumatic Treatments: A Comparison Among Synthetic Disease Modifying Anti-Rheumatic Drugs, Tumor Necrosis Factor Blockade and B-Cell Depletion For Rheumatoid Arthritis
Abstract Number: 1397

Changes In MMP In Fibroblast-Like Synoviocytes Following Adipogenesis
Abstract Number: 2869

Changes In Patient-Reported Joint Counts and Composite Indices Can Identify Flare Of Disease Activity In Recent Onset Rheumatoid Arthritis
Abstract Number: 2532

Changes In Quality Of Life In The First 5 Years Of Disease In The Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) Cohort
Abstract Number: 275

Changes In Serum IL-18 Level In Systemic Juvenile Idiopathic Arthritis Patients Who Attained Drug-Free Remission By Tocilizumab
Abstract Number: 2000

Changes In The Prevalence Of Gout In The United States General Population Between 1960 and 2010: The National Health and Nutrition Examination Surveys
Abstract Number: 333

Changes In Weight Associated With Tumour Necrosis Factor Inhibition In Psoriatic Arthritis
Abstract Number: 39

Chaperone-Mediated Autophagy As a Target Of Therapeutic P140 Peptide Used In Lupus
Abstract Number: 1390

Chaperonin Protein 14-3-3n (eta) In Rheumatoid Arthritis and Arthritogenic Viral Infections
Abstract Number: 2794

Characterisation Of Antigens Driving In Situ Autoantibody Production In Human Lupus Tubulointerstitial Nephritis (TIN)
Abstract Number: 2051

Characteristics and Comparison Of Patients With Cystic Fibrosis With and Without Arthritis
Abstract Number: 1070

Characteristics and Medication Use Patterns Among Belimumab Users In a Commercially Insured Population With Systemic Lupus Erythematosus
Abstract Number: 606

Characteristics Of Lupus Nephritis: Data From a Large Multicenter Registry Of Patients With Systemic Lupus Erythematosus
Abstract Number: 426

Characteristics of Protocol-Specified Responders/Non-Responders Treated With Etanercept Plus Methotrexate in Period 1 of the Prize Study
Abstract Number: 1620

Characterization Of a Jamaican Lupus Cohort: Proinflammatory Biomarkers and Disease Activity
Abstract Number: 1692

Characterization Of Changes In Gene Expression and Inflammatory Proteins In Systemic Juvenile Idiopathic Arthritis Patients On Canakinumab Therapy
Abstract Number: 2648

Characterization Of Histidyl-tRNA Synthetase Specific Th Cell Response In Blood and Broncheoalveolar Lavage (BAL) Of Myositis Patients
Abstract Number: 1902

Characterization Of HLA-DRB1 Distribution By 3rd Hypervariable Region Sequence In Systemic Sclerosis and Control Populations
Abstract Number: 897

Characterization Of Low Back Symptoms In a Community-Based Sample Of Older Adults: The Johnston County Osteoarthritis Project
Abstract Number: 692

Characterization Of Lower Limb Cutaneous Ulcers In Systemic Sclerosis: The Analysis of 424 Lesions
Abstract Number: 2432

Characterization Of Lung Inflammation and Identification Of Shared Citrullinated Targets In The Lungs and Joints Of Early RA
Abstract Number: 1654

Characterization Of T Cell Phenotype and Function In a Double Transgenic (Collagen-Specific TCR /HLA-DR1) Humanized Model Of Arthritis
Abstract Number: 1882

Characterizing The C-Type Lectin Domain Family 4, Member C Gene (CLEC4C) Expression In Peripheral Blood From Rheumatoid Arthritis Patients
Abstract Number: 933

Characterizing The Expression and Function Of CCL28 and Its Corresponding Receptor CCR10 In The Pathogenesis Of RA
Abstract Number: 548

Characterizing The Role Of The Granulocyte Colony Stimulating Factor Pathway In a Mouse Model Of Systemic Lupus Erythematosus
Abstract Number: 2

Charaterization Of Micrornas Involved In The Regulation Of Atherotrhombosis In Antiphospholipid Syndrome and Systemic Lupus Erythematosus
Abstract Number: 1868

Chemokine Expression In Systemic Lupus Erythematosus
Abstract Number: 1890

Chemokine Receptor Polymorphisms On Chromosome 3 Are Associated With Anticitrullinated Protein Antibody Specificities In African Americans With Rheumatoid Arthritis
Abstract Number: 401

Chest Pain Is Not Associated With Coronary Atherosclerosis In Patients With Rheumatoid Arthritis and Ankylosing Spondylitis
Abstract Number: 277

Childhood Arthritis and Rheumatology Research Alliance (CARRA) Standardized Consensus Treatment Plans for New Onset Polyarticular Juvenile Idiopathic Arthritis
Abstract Number: 605

Childhood Lupus Nephritis: Long Term Outcome Of 91biopsy Proven Cases From India
Abstract Number: 1263

Childhood-Onset Systemic Lupus Erythematosus In Ontario: Long Term Outcomes In a Population-Based Cohort With Universal Health Care Coverage
Abstract Number: 1716

Childhood-Onset Systemic Lupus Erythematosus With Clinical Neurocognitive Dysfunction Have Lower Nodal Density and Connectivity On Diffusion Tensor Imaging
Abstract Number: 290

Children With JIA Show Distinct Patterns Of Improvement In Their Health-Related Quality Of Life During The First Year On Treatment: Growth Mixture Modeling Of a Prospective Cohort Of Newly Diagnosed Patients
Abstract Number: 766

Cholesterol Accumulation By Synovial Lining Macrophages Results In Ectopic Bone Formation During Experimental Osteoarthritis
Abstract Number: 1285

Choline Kinase: A Novel Target For Rheumatoid Arthritis
Abstract Number: 70

Chondrocyte Hypertrophy, Measured By The Secretion Of Collagen Type X, Is Associated With Cartilage Degradation and Systemic Inflammation In Osteoarthritis
Abstract Number: 49

Chondrocyte-Specific Bone Morphogenetic Protein-2 Overexpression Results In Severe Aggravation Of Osteophyte Formation In Experimental Osteoarthritis Without Altering Cartilage Damage In Young Mice
Abstract Number: 1618

Chromatin Binding In SLE Patients Correlates With The Intensity Of Apoptotic Binding By 9G4+ B Cells
Abstract Number: 1782

Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperatures (CANDLE): Clinical Characterization and Initial Response To Janus Kinase Inhibition With Baricitinib
Abstract Number: 520

Chronic Obstructive Pulmonary Disease Is Very Common in Primary Sjögren’s Syndrome
Abstract Number: 696

Chronic Periaortitis With Thoracic Aorta Involvement: A New Subtype Of Large Vessel Vasculitis
Abstract Number: 1196

Chronic Renal Injury Does Not Prevent Achievement Of Target Serum Uric Acid In Tophaceous Gout
Abstract Number: 2014

Cigarette Smoking and Male Sex Are Independent Risk Factors For Ocular Sarcoidosis
Abstract Number: 1645

Circulating CD4+CD161+ T Lymphocytes Are Increased In Seropositive Arthralgia Patients But Decreased In Patients With Newly Diagnosed Rheumatoid Arthritis
Abstract Number: 659

Circulating Cell-free microRNAs in Systemic Sclerosis
Abstract Number: 1399

Citrullinated Proteoglycan (Aggrecan) Present In Human Cartilage Is Recognized By Serum Antibodies From Rheumatoid Arthritis Patients
Abstract Number: 774

Citrullination Of ENA-78/CXCL5 Changes Its Receptor Affinity From CXCR2 To CXCR1 and Induces Monocyte Migration
Abstract Number: 813

Citrulline Specific CD4+ T Cells Exhibit a Th1 Memory Phenotype In Rheumatoid Arthritis Subjects and Their Ex Vivo Frequency Is Influenced By Both Disease Duration and Biologic Therapy
Abstract Number: 256

Classification Of Alignment By Self-Report Versus Radiograph Results In Unexpected and Discrepant Pain and Functional Outcomes
Abstract Number: 2436

Classification Of Axspa Based On Positive Imaging (Radiographs and/or MRI of the Sacroiliac Joints) By Local Rheumatologists Or Radiologists Versus Central Trained Readers In The DESIR-Cohort
Abstract Number: 1924

Cleveland Clinic Dual Energy X-Ray Absorptiometry Registry, A Web-Based Tool Designed For Efficient Collection Of Bone Density and Osteoporosis Related Clinical Risk Factor Data
Abstract Number: 2190

Clinical and Immunologic Description Of Pediatric Conditions With Interferon-Regulated Gene Signatures (Chronic Atypical Neutrophilic Dermatosis Lipodystrophy Elevated Tempature, Aicardi Goutieres Syndrome, Juvenile Dermatomyositis, Juvenile Systemic Lupus Erythematosus)
Abstract Number: 2073

Clinical and Prognostic Factors Associated With Survival In Mexican Patients With Idiopathic Inflammatory Myopathies
Abstract Number: 1437

Clinical and Radiographic Outcomes At Two Years and The Effect Of Tocilizumab Discontinuation Following Sustained Remission In The Second Year Of The ACT-RAY Study
Abstract Number: 1464

Clinical and Radiographic Outcomes With Etanercept and Etanercept and Methotrexate In Patients With Rheumatoid Arthritis: Two-Year Results From The Canadian Methotrexate and Etanercept Outcome Study (CAMEO)
Abstract Number: 799

Clinical and Radiological Outcomes Of Two Years Remission Steered Treatment In Early Arthritis Patients
Abstract Number: 2508

Clinical and Serological Discordance In The Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) Cohort
Abstract Number: 127

Clinical Application Of Pain Diagrams In Fibromyalgia
Abstract Number: 2020

Clinical Characteristics In Japanese Patients With IgG4-Related Disease
Abstract Number: 328

Clinical Characteristics Of Patients Who Switch Biologic Therapy Within The First Two Years: Results From a Large US Registry Population
Abstract Number: 2478

Clinical Characteristics Of Patients With Early Spondyloarthritis. Results From a Specialized Consultation In a Clinical Hospital
Abstract Number: 2883

Clinical Characteristics of Rheumatoid Arthritis Patients with Secondary Sjögren’s Syndrome and Association with Joint Damage
Abstract Number: 2303

Clinical Characteristics Of Rheumatoid Factor-Positive Or Negative Subsets Of Anti-Citrullinated Peptide/Protein Antibody-Negative Rheumatoid Arthritis
Abstract Number: 684

Clinical Characteristics Of Scleroderma Patients With Calcinosis In a Single-Center Cohort
Abstract Number: 1560

Clinical Characterization Of Anti-CCP+Ve Systemic Lupus Erythematosus Patients
Abstract Number: 412

Clinical Characterization Of Extensive Interstitial Lung Disease In Rheumatoid Arthritis Patients
Abstract Number: 1584

Clinical Correlates Of Chronic Isolated Thrombocytopenia In Patients With Systemic Lupus Erythematosus
Abstract Number: 18

Clinical Correlates Of Positive Anti-Cardiolipin and β-2 Glycoprotein 1 Antibodies In a Cohort Of 110 Patients At Mayo Clinic
Abstract Number: 472

Clinical Efficacy Rate Of The Non-Specific Effect (the placebo effect) In The Tumour Necrosis Factor Inhibitors For Rheumatoid Arthritis Treatment After Methotrexate Failure: Meta-Analysis
Abstract Number: 8

Clinical Evaluation Of Two Anti-Beta₂glycoprotein I Domain 1 Autoantibody Assays To Aid In The Diagnosis and Risk Assessment Of The Antiphospholipid Syndrome
Abstract Number: 2062

Clinical Features and Outcome In Polymyositis Vs. Dermatomyositis Patients With The Anti-Jo-1 Autoantibody
Abstract Number: 2617

Clinical Features Of 127 Patients With Behcet’s Disease In Japan
Abstract Number: 1679

Clinical Implications Of Antiphospholipid Antibodies In Takayasu’s Arteritis
Abstract Number: 1305

Clinical Joint Involvement Is Decisive For Radiographic Progression
Abstract Number: 2486

Clinical Performance Of 4 Methods For Detecting Latent Tuberculosis Infection (LTbI) In Patients With Active Chronic Inflammatory Arthritis Taking TNFα Blockers
Abstract Number: 344

Clinical Phenotype Of Patients With Arthritis Mutilans Has Important Differences Compared To Other Patients With Psoriatic Arthritis
Abstract Number: 1061

Clinical Phenotypes and Disease Burden Of Discoid Lupus Erythematosus In a Sample Of Systemic Lupus Erythematosus Patients In The Southeastern United States
Abstract Number: 223

Clinical Predictors For Subcutaneous Power Doppler Signals Detected By Ultrasound in Hands Of Scleroderma Patients
Abstract Number: 2769

Clinical Remission After 52 Weeks Of Treatment Is a Predictor Of Adalimumab-Free Disease Control In Patients With Early Rheumatoid Arthritis: Hopeful 2 Study
Abstract Number: 735

Clinical Research Of Microscopic Polyangiitis Combined With Autoimmune Hemolytic Anemia
Abstract Number: 817

Clinical Response To Brodalumab, An Anti-Interleukin-17 Receptor Antibody, In Subjects With Psoriatic Arthritis
Abstract Number: 2592

Clinical Significance Of Endothelial Vasodilator Function Evaluated By Endopat In Patients With Systemic Sclerosis
Abstract Number: 2633

Clinical Spectrum Of Cutaneous Vasculitis
Abstract Number: 217

Clinical Value Of ¹⁸f-Fluoro-Dexoxyglucose Positron Emission Tomography In Patients With Adult-Onset Still’s Disease
Abstract Number: 756

Clinical Value Of Commonly-Measured Laboratory Tests In Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
Abstract Number: 1781

Clinical Variation In Children With Mutations In MEFV
Abstract Number: 740

Clinically Apparent Arterial Thrombosis In Persons With Systemic Vasculitis
Abstract Number: 336

Cluster Analysis Of Psoriatic Arthritis Patients At Follow-Up
Abstract Number: 760

Cluster Analysis To Explore Clinical Subclassification Of Eosinophilic Granulomatosis With Polyangiitis (Churg–Strauss)
Abstract Number: 2842

Cochrane Systematic Review Of Self-Management Education Programs For People With Osteoarthritis
Abstract Number: 2608

Coeliac Disease In Scleroderma – Clinical Features, Frequency and Impact Of Screening In Scleroderma
Abstract Number: 1259

Cognitive Dysfunction In Childhood Systemic Lupus Erythematosus: Comparison Of Different Classification Criteria
Abstract Number: 1598

Cognitive Dysfunction, a Non-Inflammatory Neuropsychiatric Syndrome In Systemic Lypus Erythematosus
Abstract Number: 1594

Cognitive Dysfunction, Depression and Anti N-Methyl-D-Aspartate Receptor Antibodies and Anti- Ribosomal P In Systemic Lupus Erythematosus Patients In Argentina
Abstract Number: 1258

Cognitive Functions In Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 1179

Colchicine Use and The Risk Of Myocardial Infarction Among Gout Patients: Interim Results From a VA Retrospective Cohort Study
Abstract Number: 1986

Colchicine Use and The Risk Of Myocardial Infarction Among Gout Patients: Results From a Community-Based, Informatics-Driven Retrospective Cohort Study
Abstract Number: 1251

Collagen Antibodies Induce Pain-Like Behavior In Mice Without Signs Of Inflammation
Abstract Number: 51

Collagen-Based Microspheres Delivering TGF-β3 For Mesenchymal STEM CELL Differentiation: An Innovative Strategy For Cartilage Engineering
Abstract Number: 714

Combination Blocking Of Interleukin-6 and Interleukin-21 In Experimental Arthritis Inhibits Their Redundant Role In T Helper 17-Driven Joint Pathology
Abstract Number: 2764

Combination of Intra-Articular Steroid Injection and Tocilizumab More Effective Than Tocilizumab in Rapid Radiographic Progression Patients With Rheumatoid Arthritis. A Randomized, Open Label, x Ray Reader Blinded Study
Abstract Number: 1960

Combination Of Magnetic Resonance Imaging-Proven Osteitis With 2010 RA Classification Criteria Improves The Diagnostic Probability Of Early Rheumatoid Arthritis Whose Disease Duration Less Than 6 Months
Abstract Number: 1833

Combination Of TNF and IL-6 Induces Osteoclast-Like Cells With Bone-Resorption Activity Both In Vitro and In Vivo
Abstract Number: 2470

Combined Axial and Peripheral Involvement Is Associated With Miscegenation In A Large and Heterogeneous Brazilian Cohort Of 1505 Patients With Spondyloarthritis
Abstract Number: 695

Combined Pulmonary Fibrosis and Emphysema (CPFE) In Systemic Sclerosis
Abstract Number: 489

Combining Methotrexate To Etanercept Does Not Improve Its Retention Rate In Rheumatoid Arthritis Patients When Compared To Etanercept Monotherapy. A Report From The Rhumadata® Clinical Data Base and Registry
Abstract Number: 2714

Commensal Intestinal Microbiota Drives Spontaneous Interleukin-1- and T Helper 17-Mediated Arthritis In Mice
Abstract Number: 408

Comorbidity In Early Rheumatoid Arthritis.Does Inflammation Matter ?
Abstract Number: 121

Comparative Burden Of Chronic Widespread Pain and Fibromyalgia In The US Population
Abstract Number: 2150

Comparative Effectiveness Of Pharmacological Interventions For Knee Osteoarthritis: A Network Meta-Analysis
Abstract Number: 1438

Comparative Effectiveness Of Rituximab Vs. Subsequent Anti-Tumor Necrosis Factor In Patients With Rheumatoid Arthritis With Prior Exposure To TNFi
Abstract Number: 460

Comparative Efficacy Of Novel Disease-Modifying Antirheumatic Drugs As Monotherapy and In Combination With Methotrexate In Rheumatoid Arthritis Patients With An Inadequate Response To Traditional Disease-Modifying Antirheumatic Drugs: A Network Meta-Analysis
Abstract Number: 2030

Comparative Immunogenicity Of Tumor Necrosis Factor Inhibitors: Impact On Clinical Efficacy and Tolerability In The Management Of Autoimmune Diseases: A Systematic Review and Meta-Analysis
Abstract Number: 2801

Comparative Longitudinal Analysis Of Periarticular Bone Structure In Patients Treated With Methotrexate In Combination Of Either TNF Blockers Or Tocilizumab
Abstract Number: 149

Comparative Proteomic Analysis Of Neutrophils From Patients With Microscopic Polyangiitis and Granulomatosis With Polyangiitis
Abstract Number: 2761

Comparative Risks Of Herpes Zoster Among RA Patients Switching Biologics In The U.S. Medicare Program
Abstract Number: 2319

Comparative Safety Of Biological Agents Among Medicare Rheumatoid Arthritis Patients
Abstract Number: 2306

Comparative Study Of Patients With Peripheral Psoriatic Arthritis, Axial Psoriatic Arthritis and Axial Spondyloarthritis Without Psoriasis
Abstract Number: 1490

Comparative Study Of The Transcriptome Of Minor Salivary Gland Of Sjögren’s Syndrome Patients Versus Healthy Controls Based On RNA-Seq
Abstract Number: 430

Comparing abatacept to Adalimumab, Etanercept and Infliximab As First Or Second Line Agents in Patients With Rheumatoid arthritis: Experience From the rhumadata® Clinical Database and Registry
Abstract Number: 335

Comparing Adalimumab and Etanercept As First Line Agents In Patients With Psoriatic Arthritis. Data From The Rhumadata® Clinical Database and Registry
Abstract Number: 363

Comparing Myocardial Infarction Risks Associated With Biologics Of Varying Mechanisms Of Action Among Older RA Patients
Abstract Number: 1398

Comparison Of Atherogenicity Of Plasma From Patients With Rheumatoid Arthritis and Psoriatic Arthritis
Abstract Number: 109

Comparison Of Characteristics In Rheumatoid Arthritis Between International and National Databases In Europe: A Systematic Literature Review
Abstract Number: 1577

Comparison Of Clinical and Serological Manifestations Among Juvenile-, Adult-, and Late-Onset Systemic Lupus Erythematosus Patients In Korea
Abstract Number: 1451

Comparison Of Clinical Characteristics Of Patients With Rheumatoid Arthritis Receiving Their First Biologic and Biologic-Naïve Patients Considered Biologic-Suitable In The United States
Abstract Number: 1019

Comparison Of Comorbidity Indexes In a Clinical and Administrative Rheumatoid Arthritis Cohort: A Case For The Rheumatic Diseases Comorbidity Index
Abstract Number: 2049

Comparison Of Corticosteroid Plus Lidocaine Or Lidocaine Alone In Patients Receiving Celecoxib For The Treatment Of Acute Shoulder Or Trochanteric Bursitis: A Randomized, Double-Blind, Placebo Controlled Trial
Abstract Number: 1906

Comparison Of Decision Rules For Identifying Patients With Systemic Lupus Erythematosus (SLE) In Administrative Healthcare Databases
Abstract Number: 2622

Comparison Of Different Methods Of Skin Pathergy Test In Patients With Behçet’s Syndrome
Abstract Number: 1449

Comparison Of Effects Of Standard- and Low-Dose Etanercept On Inflammatory Synovitis In Rheumatoid Arthritis Patients As Assessed By Ultrasonography
Abstract Number: 1042

Comparison Of Medication Usage Following Myocardial Infarction In Patients With Autoimmune Rheumatic Disease Versus Controls
Abstract Number: 2372

Comparison Of Proposed Biosimilar PF-05280586 With Rituximab: Nonclinical and Phase I Clinical Assessments
Abstract Number: 2068

Comparison Of Radioimmunoprecipitation Versus Antigen Specific Assays For Identification Of Myositis Specific Autoantibodies In Dermatomyositis Patients
Abstract Number: 1262

Comparison Of Remission Rates For Pediatric Membranous Plus Proliferative Lupus Nephritis Versus Isolated Proliferative Lupus Nephritis: An Analysis Of The Childhood Arthritis and Rheumatism Research Alliance Registry
Abstract Number: 1945

Comparison Of Selected Joint Evaluation With Comprehensive Assessment In Musculoskeletal Ultrasonography For Detection Of Synovitis In Rheumatoid Arthritis
Abstract Number: 1455

Comparison Of Serum Matrix Metalloproteinase-3 Levels In Rheumatoid Arthritis After Treatment With Adalimumub Or Abatacept For 24 Weeks
Abstract Number: 1000

Comparison Of The Cost-Effectiveness Of The Treatment Strategies With and Without Biological Response Modifiers For Patients With Recently Diagnosed Rheumatoid Arthritis Following A Clinical Guideline For Treatment Selection
Abstract Number: 2125

Comparison Of The Effectiveness Of Local Anesthetic and Corticosteroid Injections For The Treatment Of Piriformis Syndrome
Abstract Number: 1046

Comparison Of The Incidence Of Influenza Like Illness In Pregnant Women With Rheumatoid Arthritis and Women Without Rheumatoid Arthritis Who Receive An Influenza Vaccination
Abstract Number: 2238

Comparison Of The Long-Term Outcome For Rheumatoid Arthritis Patients With persistent Moderate Disease Activity Or Disease Remission During The First Year After Diagnosis: Data From The Espoir Cohort
Abstract Number: 1123

Comparison Of The Performance Of The BASRI and Msasss In Patients With Early Inflammatory Back Pain From The DESIR Cohort
Abstract Number: 2473

Comparison Of The Two Subtypes Of Axial Spondyloarthritis Patients Fulfilling The Imaging Arm Based On Radiographic and MRI Findings
Abstract Number: 2462

Comparison Of Tumor Necrosis Factor Inhibitor Use For Ankylosing Spondylitis At University Rheumatology Clinics In Scotland and Oregon
Abstract Number: 222

Comparison Of Whole Body Versus Targeted Magnetic Resonance Imaging For Assessing Disease Activity and Damage In Idiopathic Inflammatory Myopathies
Abstract Number: 201

Comparison To Organisational Models For EARLY Rheumatoid Arthritis Management: Routine Care Versus EARLY Arthritis Clinic
Abstract Number: 981

Competency and Confidence In Musculoskeletal Medicine For The First Graduating Class Of a New Medical School
Abstract Number: 1865

Complement Activation and Anaphylatoxin Generation In Response To Staphylococcal Protein A Exposure: Ex Vivo and In Vivo Human Studies
Abstract Number: 1765

Complement Component C5a Permits The Co-Existence Of Pathogenic Th17 Cells and Type I Interferon In Lupus
Abstract Number: 20

Complement Deposition On Platelets Is Associated To Venous Thrombosis In Systemic Lupus Erythematosus
Abstract Number: 2254

Complementary and Alternative Medicine in Rheumatoid Arthritis – Persistently High Use Over the Past Decade Despite Advent of Biologics
Abstract Number: 2770

Complex Functional Effects Within The HLA Contribute To Sjögren’s Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding
Abstract Number: 836

Comprehensive Behavioral Intervention Compared To Standard Of Care Exercise Program After Total Knee Arthroplasty: A Pilot Randomized Trial
Abstract Number: 2323

Comprehensive Disease Remission Achieved By Certolizumab Pegol Treatment, and Factors Associated With Certolizumab Pegol Comprehensive Disease Remission, In Rheumatoid Arthritis Patients With Predominantly High Disease Activity
Abstract Number: 1967

Computer-Aided and Manual Quantifications Of MRI Synovitis, Bone Edema, Erosion and Semi-Quantitative Cartilage Loss In Rheumatoid Arthritis
Abstract Number: 2365

Concomitant Methotrexate Did Not Affect Discontinuation Rate Of Etanercept Due To Ineffectiveness: Six-Year Results From Japanese Multicenter Registry System
Abstract Number: 1058

Concomitant Methotrexate Use and The Risk Of Drug Discontinuation For Adalimumab Compared With Etanercept In Anti-TNF-Naïve Rheumatoid Arthritis Patients: A Nationwide Population-Based Cohort Study
Abstract Number: 1120

Concordance Between ‘a Positive MRI Of The Sacroiliac joints’ Based On The Local Reading Versus a Centralised Reading: Experience From The DESIR-Cohort
Abstract Number: 261

Concordance Of Hip Pain With Radiographic Hip Osteoarthritis In An Urban US Community: The Framingham Osteoarthritis Study
Abstract Number: 2556

Concordance Of Indirect Immunofluorescence and Multiplex Immunoassay For Measurement Of Antinuclear Antibodies
Abstract Number: 1638

Concurrent Autoimmune Disease and Autoantibodies In a Large, Multi-Racial Cohort Of First Degree Blood Relatives Of SLE Patients
Abstract Number: 2357

Confounding By Indication Distorts The Relationship Between Steroid Use and Cardiovascular Disease In Rheumatoid Arthritis
Abstract Number: 2038

Congenital Heart Block Related With Maternal Autoimmune Diseases: Descriptive Analysis Of a Series Of 17 Cases
Abstract Number: 1373

Connective Tissue Growth Factor Promotes Angiogenesis Through Increased Notch-1 Signaling in Rheumatoid Arthritis
Abstract Number: 1566

Consensus Definition and Preliminary Validation Of a Low Disease Activity State In Systemic Lupus Erythematosus
Abstract Number: 417

Consensus Statement On The Diagnosis and Management Of Comorbidity In Rheumatoid Arthritis
Abstract Number: 2179

Consensus: What Agent To Use When First-Line Vasodilatadors Fail In Raynaud´s Phenomenon Or Digital Ulcers Secondary To Juvenile Systemic Sclerosis?
Abstract Number: 1587

Continuous Variables Of Treatment Interventions In Patients Diagnosed With Systemic Lupus Erythematosus Among Commercially and Medicaid Insured Populations In The U.S
Abstract Number: 219

Contrast-Enhanced Ultrasound Of The Sovraortic Arteries: The Potential Role In Monitoring Disease Activity and Response To Treatment In Large Vessel Vasculitis
Abstract Number: 1249

Contrasting Pathophysiology and Behavioural Responses Associated With Osteoarthritis and An Inflammatory Arthropathy
Abstract Number: 567

Contribution Of Marginal Zone B Cells To Autoimmunity In The B6.Sle1.Sle2.Sle3 Lupus Prone Mouse
Abstract Number: 2502

Contributions Of Skin and Joint Manifestations To The Parent-Of-Origin Effect In Psoriatic Disease
Abstract Number: 343

Conventional Dmards For Psoriatic Arthritis: Data On 1351 Treatment Courses With Methotrexate, Sulfasalazine and Leflunomide
Abstract Number: 1357

Coping Style Is An Independent Predictor For Disease Activity At Three Months In Early Arthritis Patients Initiating Therapy With Disease Modifying Anti-Rheumatic Drugs
Abstract Number: 2863

Copy Number Variations Of Complement C4A and C4B Genes Are Genetic Risk Factor and Disease Modification Factor, Respectively, For Juvenile Dermatomyositis
Abstract Number: 381

Coronary Endothelial Dysfunction Directly Measured By N13 Positron Emission Tomography (PET) Is Detected In Established Rheumatoid Arthritis (RA), But Not Early RA
Abstract Number: 954

Correlating The In Vivo Production Of IFNγ To Disease Parameters In TLR9-Induced Macrophage Activation Syndrome (MAS) In Mice
Abstract Number: 428

Correlation Between Objective and Patient Self-Reported Clinical Improvement After Multiple Courses of Rituximab in Rheumatoid Arthritis Patients With Inadequate Response to Tumour Necrosis Factor Inhibitors: Data From Repeat Study
Abstract Number: 703

Correlation Between Patient Self-Report Of Symptoms Of Raynaud’s Phenomenon and Objective Assessment Of Digital Microvascular Perfusion Using Infrared Thermography
Abstract Number: 410

Correlation of Carotid Intima Media Thickness With Interleukin-6, Tumor Necrosis Factor-α and Anti-Cyclic Citrullinated Peptides In Rheumatoid Arthritis
Abstract Number: 2521

Correlation Of Anti Single and Double Stranded DNA Antibodies and Disease Activity In Systemic Lupus Erythematosus
Abstract Number: 2289

Correlation Of Anti-Citrullinated Protein and Anti-Carp Antibodies With Disease Duration and Activity In Rheumatoid Arthritis
Abstract Number: 125

Correlation Of Findings In Clinical and High Resolution Ultrasonography Examinations Of The Painful Shoulder
Abstract Number: 2285

Correlation Of Individual Health Assessment Questionnaire (HAQ) Questions With Outcome Measures In Rheumatoid Arthritis: Implications For Instrument Reduction
Abstract Number: 1957

Correlation Of Structural Abnormalities Of The Wrist and Metacarpophalangeal Joints Evaluated By High-Resolution Peripheral Quantitative Computed Tomography, 3 Tesla MRI and Conventional Radiographs In Rheumatoid Arthritis
Abstract Number: 1741

Correlation Of The Interferon Gene Signature With Systemic Lupus Erythematosus Disease Activity Is Dependent On The Associated Level Of The BAFF Gene Transcript
Abstract Number: 2240

Correlative Analysis Of Swollen Joints Between Clinical Examination and Musculoskeletal Ultrasound For Rheumatoid Arthritis
Abstract Number: 350

Cortical Bone Density As Measured By Digital X-Ray Radiogrammetry Correlates with Radiographic Joint Damage In The Hands Within 1 Year In Psoriatic Arthritis
Abstract Number: 1585

Corticosteroid Use Across 52 Weeks Of Belimumab Therapy In Patients With Systemic Lupus Erythematosus: Combined Analyses From The BLISS Trials
Abstract Number: 1461

Corticosteroid Use In Rheumatoid Arthritis Patients On Infliximab: Treatment Implications Based On A REAL-WORLD Canadian Population
Abstract Number: 999

Cost Consideration For Biologics For Patients With Rheumatoid Arthritis In a Pharmacy Benefit Management Setting
Abstract Number: 108

Cost-Effectiveness Analysis Of Diagnostic Tests In The Work-Up Of Patients With Intermediate Risk Of Developing Rheumatoid Arthritis
Abstract Number: 2646

Cost-Effectiveness Analysis Of Triple Therapy Versus Etanercept Plus Methotrexate In Early Aggressive Rheumatoid Arthritis: Analysis Based On The TEAR Trial
Abstract Number: 1004

Cost-Effectiveness Analysis Of Two Rituximab Based Therapeutic Regimens For Longstanding Rheumatoid Arthritis
Abstract Number: 827

Cost-Effectiveness and Cost-Utility Of a One-Year Coaching Program For Healthy Physical Activity In Rheumatoid Arthritis
Abstract Number: 1771

Cost-Effectiveness Of Different Treatment Sequences Including Adalimumab In The Treat-To-Target Framework For Early Rheumatoid Arthritis In Germany
Abstract Number: 856

Cost-Effectiveness Of Urate Lowering Strategies For The Management Of Gout
Abstract Number: 2225

COVA322: A Novel, Bispecific Tumor-Necrosis-Factor-Alpha / Interleukin-17A (TNF/IL-17A) Inhibitor With Excellent Pharmacokinetic Properties In Mice and Cynomolgus Monkeys
Abstract Number: 1291

COVA322: Overcoming Limitations Of Current Biologics In Rheumatoid Arthritis By a Novel, Bispecific Tumor-Necrosis-Factor-Alpha / Interleukin-17A (TNF/IL-17A) Inhibitor Moving Towards The Clinic
Abstract Number: 308

Cross-Cultural Adaptation, Validation and Reliability Of The Brazilian Version Of The Psoriatic Arthritis Screening Evaluation Tool
Abstract Number: 133

Cross-Sectional Neurocognitive Data Do Not Support a Transition From Fibrofog To Alzheimer’s Disease In Fibromyalgia Patients
Abstract Number: 1933

Crowdsourcing Using The Audience Response System To Solve Medical Problems: A Pilot Study
Abstract Number: 2638

Cryoglobulinemia Vasculitis With Or Without Associated Cryofibrinogenemia: A Different Phenotype?
Abstract Number: 2780

Cumulative Exposure To Elevated Inflammatory Markers Is Associated With Increased Burden Of Atherosclerosis In Psoriatic Arthritis Patients: A Cohort Study
Abstract Number: 952

CX3CR1 Deficiency Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation By Predominant Infiltration Of M2 Macrophages
Abstract Number: 942

CXCL13 Is a Marker Of Joint Involvement In Early Rheumatoid Arthritis
Abstract Number: 1395

CXCL13 Is Elevated In Early and In Established Seropositive Rheumatoid Arthritis and Correlates With Rheumatoid Factor Levels
Abstract Number: 2404

CXCL13-Producing CD4 T-Cells In Rheumatoid Synovitis Are a Distinct Subset
Abstract Number: 1559

Cyclophosphamide and Rituximab Combination Treatment For Severe Systemic Lupus erythematosus is Effective and Well Tolerated
Abstract Number: 2070

Cytokine Profiles In Polymyositis and Dermatomyositis Complicated With Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Interstitial Lung Disease Or Anti-Aminoacyl tRNA Synthetase Antibody-Associated Interstitial Lung Disease
Abstract Number: 775

Cytokine-Mediated Repression Of The Lncrna Hotair Enhances Intracellular Signaling and The Expression Of Adhesion Molecules In Synovial Fibroblasts
Abstract Number: 144

Cytokines, Oxidative Stress Markers and Brain-Derived Neurotrophic Factor In Fibromyalgia Syndrome
Abstract Number: 367

Cytomegalovirus-Related Immunity Correlates With Myocardial Disease In Rheumatoid Arthritis